Document:

Exhibit 10.6

 

SALES AND SERVICE CONTRACT

FOR DAIRY PRODUCTS

 

( Ref. MPFI-GCL/12/09-01 )

 

		1.	Parties

 

This Contract is made this 25th day of
September 2012 between:

 

M-Power Food Industries Pte Ltd
a company having its principal place of business at ** (the “Seller”)

 

Seller’s bank:

 

**

 

And

 

Golden Crowne Limited a company
having its principal place of business at #1123A. Landmark North, 39 Lung Sum Avenue, Sheung Shui. NT, Hong Kong (the “Buyer”).

 

		2.	Background

 

WHEREAS, Seller has expertise in the production
of formulated dairy products (the “Dairy Products”) and is willing to provide ** to Buyer concerning the development
of its own production of such dairy products. The specifications of eighteen (18) Dairy Products are attached to this Contract
in Appendix 1.

 

WHEREAS, Seller is the sole and exclusive
owner of certain product brands and trade names (the “Brands”) and which are used with and affixed to Seller’s
Dairy Products.

 

The Brands and the Dairy Products are all
more fully identified in the Schedule A attached hereto and incorporated herein (collectively the “Products and Brands”).

 

WHEREAS, Buyer desires to obtain ** from
the Seller in order to develop production of the Dairy Products for the territory of **.

 

WHEREAS, Buyer desires to use the Brands
on the terms and conditions set forth in this Contract in connection with Buyer’s distribution of the Dairy Products, and
Seller wishes the Buyer to distribute the Dairy Products upon the terms and conditions contained in this Contract.

 

WHEREAS, Buyer recognizes that the valuable
reputation and goodwill attaching to the Brands is dependent upon the high quality of the standards established and prescribed
by the Seller. Consequently Buyer desires to comply with Seller’s quality control standards in order to preserve the reputation
and goodwill attaching to the Products and Brands.

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

NOW THEREFORE. the parties, in consideration
of the mutual covenants and agreements to be performed as set forth in this contract, the receipt and sufficiency of which consideration
are hereby acknowledged, hereby agree as follows:

 

		3.	Scope of Supply

 

Subject to the terms and conditions set
forth in this Contract, Seller will supply the followings in relation to the Products and Brands:

 

** related to the production
of the Dairy Products;

** related to the Dairy Products;

** related to the Dairy Products;

Exclusive rights to use the Brands
in connection with selling and advertising the Dairy Products

 

		4.	Territory

 

The exclusive geographical territory covered
by this Contract is **.

 

		5.	Assignment Prohibited

 

Buyer’s technical information and
know-how obtained from Seller and rights to use the Products and Brands under this Contract shall not be assigned, passed or sold
to any third party by the buyer without the prior written approval of the Seller, and an attempted assignment by the Buyer may,
at the sole discretion of the Seller, be sufficient cause for termination of this Contract. In addition, Seller may at its sole
discretion terminate this Contract upon a corporate merger or other consolidation by the Buyer.

 

		6.	Covenant Against Challenge

 

Buyer is hereby prohibited from challenging
or in any way the validity of the Brands, including its registration or its ownership by the Seller.

 

		7.	Covenant Not to Compete

 

Buyer agrees that **, the Buyer shall not
publish, market, distribute, sell or license or otherwise exploit competing products that are functionally similar to the Dairy
Products covered hereunder, or that are likely to interfere with or diminish sales of the Dairy Products covered hereunder.

 

		8.	Best Marketing Efforts

 

Buyer shall exert its best efforts to advertise,
promote and sell the Dairy Products under this Contract so as: to maintain and enhance the value of the goodwill residing in the
Products and Brands; to produce the maximum volume of sales consistent with the quality standards established by the Seller; and
to exploit the assigned territory in marketing the Dairy Products.

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		9.	** and Product and Brand Usage

 

(a)          Buyer
hereby acknowledges that ** provided by the Seller are the property of the Seller. Buyer hereby agrees to treat such ** as confidential.

 

(b)          Buyer
hereby acknowledges Seller’s right and title to the Products and Brands herein, In consideration of permitting Buyer to use
Seller’s Products and Brands, Buyer hereby agrees not to claim title to the Products and Brands and to use the Products and
Brands only as permitted by this Contract.

 

(c)          Buyer
shall prominently display the Brands on all versions of the Dairy Products in accordance with the written instructions of the Seller,
and shall use the registration symbol (r) and other registration notices correctly. Buyer shall also submit all advertising copy,
labels, stickers and packaging to the Seller ** days prior to use for written approval by the Seller.

 

(d)          Buyer
shall not adopt or use, without Seller’s prior written consent which consent shall not he unreasonably withheld any variation
oldie Products and Brands including translations and any Brand similar to or confusing with the Products and Brands. If Seller
consents to any variation of the Products and Brands, Buyer hereby agrees that Seller shall own such new Product and Brand.

 

(e)          All
goodwill arising from Buyer’s use of the Products and Brands shall inure solely to the benefit of the Seller. Buyer shall
not take any action that could be detrimental to the goodwill associated with the Products and Brands or with Seller during the
term of this Contract or after the termination of this Contract.

 

(f)           Buyer
shall during the term of this Contract and after termination thereof, execute such documents as Seller may request from time to
time to ensure that all technical information, know-how, right, title and interest in and to the Products and Brands reside with
Seller.

 

(g)          The
terms and conditions of this clause 9 shall survive any termination of this Contract.

 

		10.	Quality Control

 

(a)          Prior
to use of the Products and Brands, Buyer shall furnish to Seller for its written approval samples of the version of the products
to be sold using the Brands together with the advertising and promotional materials accompanying the products that will be displayed
(the “Sample”), Seller’s approval of the Sample shall not be unreasonably withheld. The Sample shall be deemed
approved by Seller unless Seller notifies Buyer to the contrary within ** days after receipt of the Sample. All versions of the
products manufactured, distributed, sold and advertised by Buyer shall conform to the Sample approved, or deemed approved, by the
Seller.

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

(b)          The
Buyer shall maintain the quality standards of the Dairy Products as is requested from time to time by the Seller and shall make
any changes in quality control required by the Seller. Buyer shall permit inspection of the premises of manufacture during normal
business hours; and shall follow all written specifications relating to the finished product sold by Buyer under the Brands. Seller
may also require Buyer to attend quality control training courses.

 

(c)          Buyer
shall comply at its sole expense with all applicable federal and state laws and regulations including all laws applicable to the
promotion, sale, license or sublicense, and distribution of the products.

 

		11.	Contract Value and Payment Terms

 

In consideration of all the services and
rights supplied to Buyer hereunder as more fully specified in Item 3 Scope of Supply above, Buyer shall pay to Seller a total
amount of ** as specified in the Schedule B attached hereto and incorporated herein. The acceptance by Seller of any tender
of payment in an amount which is less than the total amount due shall not be deemed a waiver of the Seller’s right to receive
the balance together with interest as is more fully specified in the Schedule B.

 

		12.	Implementation Period

 

This Contract shall be implemented within
a period of **. It may be extended upon agreement between the Seller and the Buyer.

 

		13.	Relationship of the Parties

 

The relationship of the Buyer to Seller
is that of independent contractors, and neither Buyer nor its employees or agents are employees of the Seller. This Contract does
not constitute a joint venture or grant of a franchise between Seller and Buyer.

 

		14.	Merger

 

This Contract constitutes the entire understanding
of the parties, all prior understandings having been merged herein. This Contract may only be amended only by a writing signed
by both parties to this Contract.

 

		15.	Notices

 

All notices regarding this Contract shall
be in writing and shall be deemed delivered on the earlier date; (1) if sent by e-mail, delivery or mail when actually received
and acknowledged; or (2) 5 days after mailing by certified or registered mail, return receipt requested.

 

		16.	Choice of Law

 

This Contract shall be governed by British
law. Furthermore, the parties hereby agree that any action or proceeding arising out of or relating to this Contract shall be finally
settled under the Rules of Arbitration of the International Chamber of Commerce.

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		17.	Indemnification of the Seller

 

Buyer shall defend and indemnify the Seller
and hold the Seller harmless from any and all claims, damages, and reasonable attorney’s fees and related expenses arising
from the use of the Products and Brands by the Buyer and his performance under the Contract. The provisions of this clause shall
survive the termination of this Contract for a period of **.

 

		18.	Execution

 

Each party has read this Contract in its
entirety and understands its terms and consequences. Each of the undersigned hereby represents that he or she has the authority
to enter into this Contract.

 

IN WITNESS WHEREOF the Seiler and Buyer
have executed this Contract as of the date first written above.

 

	
         Seller:

         
	M-POWER FOOD INDUSTRIES PTE. LTD.
	Authorized Signatory:	 
	 	 
	Date:	 
	
        

         
	 
	Buyer:	GOLDEN CROWNE LIMITED
	 	 
	Authorized Signatory:	 
	 	 
	Date:	 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

Schedule A – Products
and Brands

 

		·	TOP DAIRY

- Dairy Powder Chocolate 1510

- Dairy Powder Ice Cream 2615

- Dairy Powder Biscuits 2610

 

		·	C-BONLAIT

- Skimmed Milk Powder Extra Grade

- Dairy Powder 525

- Dairy Powder 1025

- Dairy Powder 1515

 

		·	LACTOSERUM

- Demineralized Whey Powder 40%

 

		·	C-MILKY

- Full Fat Milk Powder 26% Fat

- Full Fat Milk Powder Instant
28% Fat

 

		·	C-SERUM

- Sweet Whey Powder

 

		·	MILKYLAND

- Full Fat Milk Powder 26% Fat

- instant Full Fat Milk Powder
28% Fat

 

		·	OMNILAC

- Whole Milk Powder 26% Fat

- Instant Whole Milk Powder 28%
Fat

- Full Fat Milk Powder 26% Fat

- Instant Full Fat Milk Powder
28% Fat

 

		·	COUNTRY LAND

- Skimmed milk Powder

 

     

     

    

 

Schedule B — Payment
Terms

 

As per Clause 11 of the Sales and Service
Contract, Buyer will pay ** to Seller for a total amount of ** covering ** and Products and Brand usage covering the Products and
Brands as specified in Schedule A of the Contract.

 

Seller shall issue to Buyer partial invoices
for the payment, which should be as follows, unless otherwise agreed by the Parties:

 

**

 

Unless any change to be agreed between
Seller and Buyer, the invoice payment terms will be as follows:

 

**

 

Buyer acknowledges that time is of the
essence in the prompt submission of payments. Any late payment will bear interest at the rate of ** per month.

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

Appendix 1 – Dairy Product
Specifications (18 pages)

 

     

     

    

 

	
        
	Dairy
    Powder

    Chocolate 1510

 

Applications

Excellent for Chocolate, Desserts, others.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Dairy
    Powder

    Ice cream 2615

 

Applications

Excellent in Bakery, Ice cream, Frozen
desserts, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Dairy
    Powder

    Biscuits 2610

 

Applications

Excellent for biscuits, cookies, and other
applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Skimmed
    Milk Powder

    Extra Grade

 

Applications

Ice cream, Yoghurt, Dairy Beverages, Recombined
Milk, Bakery, Chocolate, Desserts, Confectionery, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Dairy
    Powder 525

 

Applications

Excellent in Bakery applications.

 

Ingredients

**

 

Aspect

Light cream colour, milky taste and flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Packing

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal. the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Dairy
    Powder 1025

 

Applications

White Cheese, Yoghurt, Desserts, Others.

 

Aspect

Light cream colour, typical taste and flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Packing

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Dairy
    Powder 1515

 

Applications

Yoghurt, Desserts, Others.

 

Ingredients

**

 

Aspect

Light cream colour, typical taste and flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Packing

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Demineralized

    Whey Powder 40%

 

Applications

Ice cream, Bakery, Confectionery, Yoghurt,
Desserts, Chocolate, Blends, Dry mixes, and other applications.

 

Aspect

Light cream to creamy colour, natural flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

  

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Full
    Fat Milk Powder

    26% Fat

 

Applications

Dairy Beverages, Ice cream, Recombined
Milk, Bakery, Chocolate, Desserts, Confectionery, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

  

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Full
    Fat Milk Powder

    28% Fat

 

Applications

Dairy Beverages, Ice cream, Recombined
Milk, Bakery, Chocolate, Desserts, Confectionery, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

  

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		Sweet
    Whey Powder

 

Applications

Partial replacer to skimmed milk powder
in applications such as Ice cream, Bakery, Confectionery, Ready to cook dishes, Chocolate, Dairy based products, and other applications.

 

Aspect

Light cream colour, typical taste and flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

  

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

	
        

        
	Full
    Fat Milk Powder 

26% Fat

 

Applications

Ice cream, Dairy based Beverages, Chocolate,
Processed cheese & spreads, Ready to cook dishes, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

  

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

	
         

        
	Full
    Fat Milk Powder 

28% Fat

 

Applications

Ice cream, Bakery, Dairy Beverage, Chocolate,
Desserts, Confectionery, Recombined Milk, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

  

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		
        

        Whole
        Milk Powder

 

Applications

Ice cream, Bakery, Dairy Beverage, Chocolate,
Desserts, Confectionery, Recombined Milk, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		
        

        Instant
        Whole Milk Powder

        28% Fat

 

Applications

Ice cream, Bakery, Dairy Beverage, Chocolate,
Desserts, Confectionery, Recombined Milk, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

  

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		
        

        Full
        Fat Milk Powder

        26% Fat

 

Applications

Ice cream, Dairy based Beverages, Chocolate,
Processed cheese & spreads, Ready to cook dishes, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

  

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

		
        

        Instant
        Full Fat Milk Powder

        28% Fat

 

Applications

Ice cream, Bakery, Dairy Beverage, Chocolate,
Desserts, Confectionery, Recombined Milk, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour.

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shelf Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

  

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.

 

     

     

    

 

	 	Skimmed
    Milk Powder

 

Applications

Ice cream, Yoghurt, Dairy Beverages, Recombined
Milk, Bakery, Chocolate, Desserts, Confectionery, and other applications.

 

Aspect

Light cream colour, pleasant taste, milky
flavour,

 

Typical Chemical & Physical Analysis

**

 

Typical Microbiological Analysis

**

 

Packaging

Product is packed in 25kg net paper printed
bags with PE liner.

 

Loading

**

 

Storage and Shell Life

The product shelf life is **. Goods are
recommended to be stored in a cool and dry clean place away from all sources of heat and odour. Prolonged exposure to light should
be avoided. If partially used bags of product are stored, care should be taken to seal the PE liner in order to prevent the uptake
of moisture which can give rise to caking or lump formations in the powder.

 

Origin

Singapore.

 

Note:
The data outlined are intended as a source of information only. It is subject to improvement or change without prior notice.

 

 

 

**          Certain information on this page has
been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the
omitted portions.Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 8, 2015 (the “Effective Date”), is by and between Diligent Corporation, a Delaware corporation (the “Company”) and Michael Stanton (“Executive”).  Certain other capitalized terms used herein are defined in Section 7.17 below and throughout this Agreement.

 

W I T N E S S E T H:

 

WHEREAS, the Company desires to employ Executive as its Chief Financial Officer and Executive Vice President and Executive desires to be so employed by the Company on the terms specified herein; and

 

WHEREAS, the Company and Executive each believe it is in their respective best interests to enter into this Agreement setting forth the mutual understandings and agreements reached between the Company and Executive with respect to Executive’s employment with the Company and certain restrictions on Executive’s conduct benefiting the Company during such time and thereafter, all as set forth herein; and.

 

WHEREAS, the Company and Executive have entered into the Company’s standard form of director and officer indemnity agreement concurrently herewith.

 

NOW, THEREFORE, in consideration of the promises and the mutual covenants and agreements contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intended to be legally bound hereby, agree as follows:

 

ARTICLE 1
 TERM OF AGREEMENT AND EMPLOYMENT

 

Section 1.1.                                 Employment and Acceptance.  During the Term (as defined in Section 1.2 below), the Company shall employ Executive to render full time services to the Company, and Executive shall accept such employment and serve the Company, subject to the terms of this Agreement.

 

Section 1.2.                                 Term.  The term of Executive’s employment hereunder shall commence on the Effective Date and shall continue until the termination of Executive’s employment hereunder by either party pursuant to the provisions of Article 5 herein (the “Term”).

 

ARTICLE 2
  TITLE; DUTIES AND OBLIGATIONS; LOCATION

 

Section 2.1.                                 Title.  During the Term, Executive shall serve in the capacity of Chief Financial Officer and Executive Vice President, subject to the terms of this Agreement.

 

Section 2.2.                                 Duties.  Subject to the direction and authority of the Chief Executive Officer of the Company (the “CEO”), Executive will perform such executive duties customarily 

 

 

performed by a chief financial officer and executive vice president of a company in similar lines of business as the Company, including directing the organization’s financial planning, accounting practices, internal controls over financial reporting, filings of periodic financial reports with the Securities and Exchange Commission and other applicable regulatory bodies, as well as taking a leading role in managing the organization’s relationship with lending institutions, shareholders, and the financial community, and such duties as may be assigned by the CEO.  Executive shall report to, and be subject to the lawful direction of, the CEO.  Executive agrees to perform to the best of his ability, experience and talent those acts and duties, consistent with the position of Chief Financial Officer and Executive Vice President of the Company, as the CEO shall from time to time direct.  Executive may not engage, directly or indirectly, in any other business, investment or other activity that interferes with Executive’s performance of his duties and responsibilities hereunder, is contrary to the interest of the Company or any of its subsidiaries, or requires any significant portion of Executive’s business time.  The foregoing notwithstanding, the parties recognize and agree that Executive may manage his passive personal investments and engage in civic, charitable or religious activities that (in each case) do not conflict with the business and affairs of the Company or interfere with Executive’s performance of his duties and responsibilities hereunder.  Executive may not serve on the board of directors (or similar governing body) of any entity other than the Company or its subsidiaries during the Term without the prior written approval of the Board of Directors of the Company (the “Board”).

 

Section 2.3.         Other Positions. During the Term, upon determination of the Board, Executive may be appointed as an officer and/or or nominated for election to any governing body of, any subsidiary of the Company for no additional compensation.  In addition, at the election of the Board, Executive shall also serve as Treasurer of the Company.

 

Section 2.4.                                 Compliance With Policies, etc.  During the Term, Executive shall adhere to the Company’s policies, rules and regulations governing the conduct of its employees, now in effect, or as subsequently adopted or amended, including, but not limited to, the Company’s Code of Conduct.

 

Section 2.5.                                 Location.  Executive shall perform his services principally at the Company’s headquarters in New York City.  Notwithstanding, the foregoing, Executive shall be required to travel as necessary to perform his duties hereunder.

 

ARTICLE 3
 COMPENSATION

 

Section 3.1.                                 Base Compensation.  During the Term, the Company shall pay Executive a base salary at the annualized rate of $375,000, which shall be subject to withholding and customary deductions and be payable in equal installments in accordance with the Company’s then-customary payroll practices for its executives (the “Base Salary”), and may be increased at the sole discretion of the Compensation Committee of the Board (the “Compensation Committee”).

 

Section 3.2.                                 Annual Bonus.  In addition to the Base Salary, Executive shall be eligible for an annual cash bonus (the “Bonus”) for each fiscal year completed during the Term in an 

 

2

 

amount determined by the Compensation Committee in its sole discretion based on the achievement of performance targets established by the Compensation Committee.  Executive’s target annual bonus shall not be less than $250,000, payable at one hundred percent (100%) achievement of all applicable performance targets for the year, as determined by the Compensation Committee in its sole discretion.  In addition, Executive shall be permitted to earn a lesser or greater Bonus for performance levels below or above the targets for a fiscal year as established by the Compensation Committee, based on the same criteria made available to the Company’s other executive officers; provided, that if the minimum performance targets for a fiscal year as established by the Compensation Committee are not satisfied, no Bonus will be payable for such fiscal year.  Any Bonus payable hereunder shall be paid in the fiscal year following the fiscal year to which such Bonus relates and within thirty (30) days following completion of the Company’s annual financial audit, subject to Executive’s continued employment with the Company at the time of payment.  The Bonus for fiscal 2015 performance shall be prorated based on the portion of 2015 for which Executive is employed, subject to Executive’s continued employment with the Company at the time of payment.

 

Section 3.3.                                 Sign-On Bonus.  Executive shall be eligible for a sign-on bonus of $85,000 (the “Sign-On Bonus”).  The Sign-On Bonus is payable thirty (30) days following the Effective Date, subject to Executive’s continued employment with the Company at the time of payment.

 

Section 3.4.                                 Relocation Payment.  The Company shall pay Executive an amount equal to $100,000 (the “Relocation Payment”) to cover Executive’s costs related to the relocation of Executive’s primary residence from the Arlington, Virginia metropolitan area to the New York City, New York metropolitan area (the “Relocation”).  The Relocation Payment is payable on or before March 31, 2016, subject to Executive’s continued employment with the Company at the time of payment.  Executive hereby covenants and agrees to use his best efforts to complete the Relocation on or prior to January 31, 2016.  The full amount of the Relocation Payment is recoverable by the Company in the event the Relocation does not occur prior to March 31, 2016.

 

Section 3.5.                                 Equity Awards.  The Board and/or the Compensation Committee (or a subcommittee thereof) has approved, effective upon Executive’s commencement of services hereunder, an equity incentive grant to Executive pursuant to the Company’s 2013 Incentive Plan (the “Plan”) consisting of (i) 120,000 Restricted Share Units (as defined in the Plan) covering shares of the Company’s common stock, par value $.001 per share (the “Common Stock”), pursuant to the Plan (the “Restricted Share Units”), (ii) an option to purchase 240,000 shares of the Company’s Common Stock (the “Option”) with a per share exercise price equal to the United States dollar equivalent of the Company’s closing stock price on the New Zealand Stock Exchange on the day immediately prior to the Effective Date and (iii) a performance-based Restricted Share Unit Award granting Executive up to 240,000 shares of Common Stock upon the achievement of Performance Goals (as defined in Exhibit A-3) pursuant to the Plan.  The Awards shall be documented in Award Agreements (as defined in the Plan) between the Company and Executive in the forms attached as Exhibit A-1, Exhibit A-2 and Exhibit A-3 hereto.

 

3

 

ARTICLE 4
 BENEFITS AND EXPENSES

 

Section 4.1.                                 Benefit Plans.  Executive shall be entitled to participate in all benefit plans (excluding severance plans, if any) generally available to other senior executives of the Company on the same basis and to the same extent as other senior executives.  Executive shall be entitled to paid vacation on the same basis generally available to other senior executives of the Company, but no less than four (4) weeks of paid vacation annually during the Term (pro rated for partial years), which Executive shall take during such times as shall be consistent with Executive’s responsibilities.

 

Section 4.2.                                 Expense Reimbursement.  The Company shall reimburse Executive during the Term, in accordance with the Company’s policies, for out-of-pocket business expenses incurred by Executive in the performance of his duties hereunder.  In order to receive such reimbursement, Executive shall furnish to the Company documentary evidence of each such expense in the form required to comply with the Company’s policies.

 

ARTICLE 5
 TERMINATION OF EMPLOYMENT

 

Section 5.1.                                 Termination Without Cause or Resignation For Good Reason.

 

(a)         The Company may terminate Executive’s employment hereunder at any time without Cause (other than by reason of Disability) upon written notice to Executive.  Executive may terminate his employment hereunder for Good Reason upon written notice to the Company in accordance with the definition thereof.

 

(b)         If Executive’s employment is terminated pursuant to Section 5.1(a), the Company shall have no further obligation to make or provide to Executive, and Executive shall have no further right to receive or obtain from the Company, any payments or benefits except:

 

(i)             the Company shall pay to Executive the Accrued Obligations;

 

(ii)          the Company shall pay to Executive an amount equal to six (6) months of Executive’s Base Salary (as in effect immediately prior to the date of termination), which amount shall increase to twelve (12) months of Executive’s Base Salary (as in effect immediately prior to the date of termination for any termination occurring after the date on which the Relocation is complete) on the date that Executive provides the Company with a written statement certifying that Executive has completed the Relocation, which shall be payable, subject to Section 5.1(b) and Section 5.5, in equal installments in accordance with the Company’s then-customary payroll practices for executives (the “Severance Payments”); and

 

Executive shall be entitled to exercise outstanding options or other equity-based awards granted by the Company to Executive in accordance with the terms of the applicable incentive plan and award agreements.

 

4

 

(c)          With the exception of the Accrued Obligations, the Company’s payment of the amounts set forth in Section 5.1(b) shall be contingent upon Executive executing the Release described in Section 7.12 below, which must be executed by Executive and become effective (and non-revocable) within sixty (60) days after the Termination Date.  Subject to Section 5.5 hereof, the payments set forth in Section 5.1(b)(ii), if applicable, shall commence on the first regular payroll date of the Company that occurs after the date that is sixty (60) days after the Termination Date and the first installment of such payments shall include the cumulative amount of payments that would have been paid to Executive during the period of time between the Termination Date and the commencement date had such payments commenced immediately following the Termination Date.  With the exception of the Accrued Obligations, the Company shall have no obligation to provide any of the payments set forth in Section 5.1 in the event that Executive breaches the provisions of Article 6 of this Agreement.

 

Section 5.2.                                 Termination for Cause; Voluntary Termination.

 

(a)         The Company may terminate Executive’s employment hereunder at any time for Cause upon written notice to Executive.  Executive may voluntarily terminate his employment hereunder at any time without Good Reason upon sixty (60) days prior written notice to the Company.

 

(b)         If Executive’s employment terminates pursuant to Section 5.2(a), the Company shall pay to Executive the Accrued Obligations; provided that in the event such termination of Executive’s employment occurs on or before January 31, 2016, Executive shall be required to immediately remit and repay to the Company an amount equal to one hundred percent (100%) of the Sign-On Bonus and the Relocation Payment without any reduction for employment, income or other taxes initially withheld on such amounts when paid to Executive; provided further that the Company may, in its sole discretion and subject to applicable law, deduct such amount from the Accrued Obligations in satisfaction of Executive’s obligation to remit an amount equal to the Sign-On Bonus and the Relocation Payment in the event such termination of Executive’s employment pursuant to Section 5.2(a) occurs on or before January 31, 2016 (and any remaining balance shall be immediately repaid to the Company by Executive).

 

Section 5.3.                                 Termination Resulting from Death or Disability.

 

(a)         As the result of any Disability suffered by Executive, the Company may, upon five (5) days prior notice to Executive, terminate Executive’s employment under this Agreement.  Executive’s employment shall automatically terminate upon his death.

 

(b)         If Executive’s employment is terminated pursuant to Section 5.3(a), Executive or Executive’s estate, as the case may be, shall be entitled to receive, and the Company’s sole obligation under this Agreement or otherwise shall be to pay or provide to Executive or Executive’s estate, as the case may be, the Accrued Obligations.

 

Section 5.4.                                 Removal from any Boards and Position.  If Executive’s employment is terminated for any reason under this Agreement, he shall be deemed (without further action, deed or notice) to resign (i) if a member, from the board of directors of any subsidiary of the Company or any other board to which he has been appointed or nominated by or on behalf of the Company 

 

5

 

and (ii) from all other positions with the Company or any subsidiary of the Company, including, but not limited to, as an officer of the Company and any of its subsidiaries.

 

Section 5.5.                                 409A Compliance.  All payments under this Agreement are intended to comply with or be exempt from the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”).  To the extent that any provision in this Agreement is ambiguous as to its compliance with Section 409A, or to the extent any provision in this Agreement must be modified to comply with Section 409A, such provision shall be read, or shall be modified, as the case may be, in such a manner so that no payment due to Executive shall be subject to an “additional tax” within the meaning of Section 409A(a)(1)(B).  If necessary to comply with the restriction in Section 409A(a)(2)(B) of the Code concerning payments to “specified employees,” any payment on account of Executive’s separation from service that would otherwise be due hereunder within six (6) months after such separation shall be delayed until the first business day of the seventh month following the Termination Date and the first such payment shall include the cumulative amount of any payments (without interest) that would have been paid prior to such date if not for such restriction.  Each payment in a series of payments hereunder shall be deemed to be a separate payment for purposes of Section 409A. To the extent required to avoid an accelerated or additional tax under Section 409A, amounts reimbursable to Executive under this Agreement shall be paid to Executive on or before the last day of the year following the year in which the expense was incurred and the amount of expenses eligible for reimbursement (and in-kind benefits provided to Executive) during any one year may not affect amounts reimbursable or provided in any subsequent year.  In no event whatsoever shall the Company be liable for any additional tax, interest or penalty that may be imposed on Executive by Section 409A or damages for failing to comply with Section 409A.

 

ARTICLE 6
 NON-COMPETITION, CONFIDENTIALITY AND
  NON-SOLICITATION COVENANTS

 

Section 6.1.                                 Non-Competition, Confidentiality, etc.

 

(a)         Executive acknowledges that Executive’s employment hereunder will provide Executive with access on a continual basis to confidential and proprietary information concerning the Business, the Company and its Affiliates, which is not readily available to the public and that the Company would not enter into this Agreement but for the covenants (the “Restrictive Covenants”) contained in this Article 6 and the Company’s Assignment of Inventions, Non-Disclosure and Non-Solicitation Agreement, attached hereto as Exhibit B (“Non-Disclosure Agreement”), which shall be executed on the Effective Date by Executive.

 

(b)         To the extent permitted by applicable law, in consideration for the salary and other payments to be provided to Executive pursuant to this Agreement, during the Term and for a period of twelve (12) months thereafter (the Term and such twelve (12) month period, the “Restricted Period”), Executive agrees not to directly or indirectly, whether as an officer, employee, agent, partner, owner, lender, investor, consultant or otherwise, anywhere in the world: (i) compete with the Business or engage in the Business for his own account or for the account of any other person or entity, or (ii) engage in any other activity conducted or proposed to be conducted by the Company at the time of such termination, provided, however, that

 

6

 

Executive may own, directly or indirectly, solely as a passive investment, securities of any entity which are traded on any national securities exchange, if Executive is not a controlling person of, or a member of a group which controls, such entity, and in any event, does not, directly or indirectly, beneficially own two percent (2%) or more of any class of securities of such publicly traded entity.

 

(c)          The Restricted Period shall be extended for an amount of time equal to the time period during which Executive was in violation of any provision of this Article 6 and shall continue through any action, suit or proceedings arising out of or relating to this Article 6.

 

(d)         This Article 6 and the Non-Disclosure Agreement shall survive any termination or expiration of this Agreement or the Term.

 

Section 6.2.                                 Reasonableness; Injunction.  Executive acknowledges and agrees that (i) Executive has had an opportunity to seek advice of counsel in connection with this Agreement and the Non-Disclosure Agreement, (ii) the Restrictive Covenants are reasonable in scope and in all other respects, (iii) any violation of the Restrictive Covenants will result in irreparable injury to the Company, (iv) money damages would be an inadequate remedy at law for the Company in the event of a breach of any of the Restrictive Covenants by Executive, (v) specific performance in the form of injunctive relief would be an adequate remedy for the Company, and (vi) the Restrictive Covenants shall be deemed a series of independent covenants in each jurisdiction in which they apply, and the invalidity or impairment of any Restrictive Covenant in any one such jurisdiction shall not affect the enforceability of the Restrictive Covenants in each and every other jurisdiction.  If Executive breaches or threatens to breach a Restrictive Covenant, the Company shall be entitled, in addition to all other remedies, to an injunction restraining any such breach, without any bond or other security being required and without the necessity of showing actual damages.  In addition, the Company shall be entitled to recover all reasonable attorneys’ fees and expenses incurred in connection with enforcing its rights under this Agreement and the Non-Disclosure Agreement.  Executive further agrees that a copy of a summons and complaint seeking the entry of an order to enforce its rights hereunder may be served upon Executive by certified mail, return receipt requested, at the address set forth in Section 7.5 below or at any other address which Executive shall designate in accordance with Section 7.5.

 

Section 6.3.                                 Nondisparagement.  Executive agrees that he will not at any time (whether during or after the Term) publish or communicate to any person or entity any Disparaging (as defined below) remarks, comments or statements concerning the Company and its subsidiaries, and their respective present and former members, partners, directors, officers, shareholders, employees, agents, attorneys, successors and assigns (the “Protected Parties”).

 

ARTICLE 7
 GENERAL PROVISIONS

 

Section 7.1.                                 Expenses.  Each of the Company and Executive shall bear its own costs, fees and expenses in connection with the negotiation, preparation and execution of this Agreement.  Notwithstanding the foregoing to the contrary, the prevailing party in any dispute under this Agreement shall be entitled to recover from the losing party all fees, expenses and 

 

7

 

costs (including without limitation, attorneys fees and expenses) incurred by the prevailing party in connection with such dispute.

 

Section 7.2.                                 Key-Man Insurance.  Upon the Company’s request, Executive shall cooperate (including, without limitation, taking any required physical examinations) in all respects in obtaining a key-man life insurance policy on the life of Executive in which the Company is named as the beneficiary.

 

Section 7.3.                                 Entire Agreement.  This Agreement when executed, contains a complete statement of all of the terms of the arrangements between Executive and the Company with respect to Executive’s employment by the Company and supersedes any and all other agreements and understandings, whether oral or in writing, between the parties hereto with respect to the subject matter hereof.  Each party acknowledges that no representations, inducements, promises or agreements, whether oral or in writing, have been made by any party, or on behalf of any party, which are not embodied herein.  No agreement, promise or statement not contained in this Agreement shall be valid and binding, unless agreed to in writing and signed by the parties sought to be bound thereby.

 

Section 7.4.                                 No Other Contracts.  Executive represents and warrants to the Company that neither the execution and delivery of this Agreement by Executive nor the performance by Executive of Executive’s obligations hereunder, shall constitute a default under or a breach of the terms of any other agreement, contract or other arrangement, whether written or oral, to which Executive is a party or by which Executive is bound, nor shall the execution and delivery of this Agreement by Executive nor the performance by Executive of his duties and obligations hereunder give rise to any claim or charge against either Executive, the Company or any Affiliate, based upon any other contract or other arrangement, whether written or oral, to which Executive is a party or by which Executive is bound.  Executive further represents and warrants to the Company that he is not a party to or subject to any restrictive covenants, legal restrictions or other agreement, contract or arrangement, whether written or oral, in favor of any entity or person which would in any way preclude, inhibit, impair or limit Executive’s ability to perform his obligations under this Agreement, including, but not limited to, non-competition agreements, non-solicitation agreements or confidentiality agreements.  Executive shall defend, indemnify and hold the Company harmless from and against all claims, actions, losses, liabilities, damages, costs and expenses (including reasonable attorney’s fees and amounts paid in settlement in good faith) arising from or relating to any breach of the representations and warranties made by Executive in this Section 7.4.

 

Section 7.5.                                 Notices.  Any notice or other communication required or permitted hereunder shall be in writing and shall be delivered personally, faxed, or sent by nationally recognized overnight courier service (with next business day delivery requested).  Any such notice or communication shall be deemed given and effective, in the case of personal delivery, upon receipt by the other party, in the case of faxed notice, upon written receipt of transmission of the fax, in the case of a courier service, upon the next business day, after dispatch of the notice or communication.  Any such notice or communication shall be addressed as follows:

 

8

 

	
If to   the Company, to:
    
	
 
    
	
 
    	
Diligent Corporation
    
	
 
    	
1385 Broadway, 19th Floor
    
	
 
    	
New York, New York 10018
    
	
 
    	
Attn: Corporate Secretary
    
	
 
    	
 
    
	
If to   Executive, to:
    
	
 
    
	
 
    	
Michael Stanton
    
	
 
    	
[                   ]
    
	
 
    	
[                   ]
    

 

Any person named above may designate another address or fax number by giving notice in accordance with this Section to the other persons named above.

 

Section 7.6.                                 Governing Law.  This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York, without regard to principles of conflicts of law.

 

Section 7.7.                                 Waiver.  Either party may waive compliance by the other party with any provision of this Agreement.  The failure of a party to insist on strict adherence to any term of this Agreement on any occasion shall not be considered a waiver or deprive that party of the right thereafter to insist upon strict adherence to that term or any other term of this Agreement.  No waiver of any provision shall be construed as a waiver of any other provision.  Any waiver must be in writing.

 

Section 7.8.                                 Severability.  If any one or more of the terms, provisions, covenants and restrictions of this Agreement shall be determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated and the parties will attempt to agree upon a valid and enforceable provision which shall be a reasonable substitute for such invalid and unenforceable provision in light of the tenor of this Agreement, and, upon so agreeing, shall incorporate such substitute provision in this Agreement.  In addition, if any one or more of the provisions contained in this Agreement shall for any reason be determined by a court of competent jurisdiction to be excessively broad as to duration, geographical scope, activity or subject, it shall be construed, by limiting or reducing it, so as to be enforceable to the extent compatible with then applicable law.

 

Section 7.9.                                 Counterparts.  This Agreement may be executed in any number of counterparts and each such duplicate counterpart shall constitute an original, any one of which may be introduced in evidence or used for any other purpose without the production of its duplicate counterpart.  Moreover, notwithstanding that any of the parties did not execute the same counterpart, each counterpart shall be deemed for all purposes to be an original, and all such counterparts shall constitute one and the same instrument, binding on all of the parties hereto.

 

9

 

Section 7.10.                          Advice of Counsel.  Both parties hereto acknowledge that they have had the opportunity to seek and obtain the advice of counsel before entering into this Agreement and have done so to the extent desired, and have fully read the Agreement and understand the meaning and import of all the terms hereof.

 

Section 7.11.                          Assignment.  This Agreement shall inure to the benefit of the Company and its successors and assigns and shall be binding upon the Company and its successors and assigns.  This Agreement is personal to Executive, and Executive shall not assign or delegate his rights or duties under this Agreement, and any such assignment or delegation shall be null and void.

 

Section 7.12.                          Release.  Notwithstanding anything to the contrary in this Agreement, with the exception of the Accrued Obligations, Executive shall not be entitled to receive any post-employment compensation pursuant to Section 5.1(b) hereof, unless prior to the receipt of such compensation, Executive executes and delivers to the Company a release, in form and substance satisfactory to the Company under which Executive releases and discharges the Company and its subsidiaries and Affiliates and each of their respective officers, directors, shareholders, partners, managers, agents, employees and other related parties, from any claims and causes of action of any kind, including, but not limited to, claims and causes of actions arising out of Executive’s employment or termination of employment, but excluding claims and causes of action arising solely out of the obligations of the Company to make payments or provide benefits to Executive after the termination of such employment pursuant to the express provisions of the Agreement.

 

Section 7.13.                          Agreement to Take Actions.  Each party to this Agreement shall execute and deliver such documents, certificates, agreements and other instruments, and shall take all other actions, as may be reasonably necessary or desirable in order to perform his or its obligations under this Agreement.

 

Section 7.14.                          No Attachment.  Except as required by law, no right to receive payments under this Agreement shall be subject to anticipation, commutation, alienation, sale, assignment, encumbrance, charge, pledge, or hypothecation or to execution, attachment, levy or similar process or assignment by operation of law, and any attempt, voluntary or involuntary, to effect any such action shall be null, void and of no effect; provided, however, that nothing in this Section 7.14 shall preclude the assumption of such rights by executors, administrators or other legal representatives of Executive or Executive’s estate and their assigning any rights hereunder to the person or persons entitled thereto.

 

Section 7.15.                          Tax Withholding.  The Company or other payor is authorized to withhold from any benefit provided or payment due hereunder, the amount of withholding taxes due any federal, state or local authority in respect of such benefit or payment and to take such other action as may be necessary in the opinion of the Board to satisfy all obligations for the payment of such withholding taxes.

 

10

 

Section 7.16.                          Limitation on Parachute Payments.

 

(a)  In the event that the payments or other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G(b)(2) of the Code, and (ii) would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then Executive’s benefits under this Agreement shall be either (x) delivered in full, or (y) delivered to such lesser extent which would result in no portion of such benefits being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Executive on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code. If a reduction in payments or benefits constituting “parachute payments” is necessary pursuant to the foregoing provision, reduction shall occur in the following order: reduction of cash payments; reduction of employee benefits, and cancellation of accelerated vesting of stock-based compensation and awards. If acceleration of vesting of stock-based compensation and awards is to be reduced, such acceleration of vesting shall be cancelled in the reverse order of the date of grant of Executive’s stock awards.

 

(b)  Unless the Company and Executive otherwise agree in writing, any determination required under this Section 7.16 shall be made in writing by the Company’s independent public accountants (the “Accountants”), whose determination shall be conclusive and binding upon Executive and the Company (absent manifest error) for all purposes and may be relied upon by the Company. For purposes of making the calculations required by this Section 7.16, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Section 280G and 4999 of the Code. The Employee shall provide to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section 7.16. The Company shall bear all costs the Accountants may reasonably incur in connection with any calculations contemplated by this Section 7.16.

 

Section 7.17.                          Definitions.  The following definitions apply to this Agreement:

 

(a)                       “Accrued Obligations” means (i) Executive’s accrued but unpaid Base Salary through the final date of Executive’s employment by the Company (the “Termination Date”), payable in accordance with the Company’s standard payroll practices, (ii) Executive’s accrued but unused accrued vacation (in accordance with the Company’s policies), (iii) expenses reimbursable under Section 4.2 incurred on or prior to the Termination Date but not yet reimbursed and (iv) any accrued and unpaid amounts due and owing under any Company health plan in which Executive participates, in accordance with the terms of such plan(s).

 

(b)                       “Affiliate” means, with respect to a specified entity, any individual or entity that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, the specified entity.

 

(c)                        “Business” means the business of manufacturing, providing or marketing (i) software for digital board books or board portals—whether delivered via the Application Service Provider model or as installed software—to desktop PCs, laptops, PDAs, mobile phones and computing devices (or other form of computing or electronic device), (ii) enterprise collaboration software, products and services of the Company currently under development or developed 

 

11

 

during the Term and (iii) and any additional businesses presently or hereafter conducted by the Company and its Affiliates during the period of time in which Executive is employed by the Company or any of its Affiliates.

 

(d)                       “Cause” means: (i) Executive commits a material act of dishonesty, deceit, or breach of fiduciary duty in the performance of Executive’s duties as an employee of the Company; (ii) Executive neglects or fails on a recurring basis and in a material respect, to perform Executive’s job duties as defined in Section 2 hereof; (iii) Executive substantially violates any written policy or reasonable expectation of the Company regarding employee behavior or conduct that has been communicated to Executive by the Company or such employee behavior or conduct is outside the remit of Executive’s job description and Executive does not cure such breach within thirty (30) days after written notice from the Company; (iv) Executive is convicted of, or pleads nolo contendere, to (a) any felony, or any misdemeanor involving moral turpitude or (b) any crime or offense involving dishonesty with respect to the Company or (v) Executive materially breaches any provision of this Agreement and does not cure such breach within thirty (30) days after written notice from the Company, except that such cure period shall not apply to any breach by Executive of the Restrictive Covenants.

 

(e)                        “Disability” means a determination by the Company in accordance with applicable law that as a result of a physical or mental injury or illness, Executive is unable to perform the essential functions of his job, including with a reasonable accommodation, for a period of (i) ninety (90) consecutive days; or (ii) one hundred eighty (180) days during any twelve (12) month period.

 

(f)                         “Disparaging” refers to those remarks, comments or statements that impugn the character, honesty, integrity or morality or business acumen or abilities in connection with any aspect of the operation of business of the individual or entity being disparaged.

 

(g)                        “Good Reason” means the occurrence of any of the following: (1) a material breach by the Company of the terms of this Agreement; (2) a material reduction in Executive’s Base Salary or target Bonus without Executive’s consent, which consent shall be determined in Executive’s discretion; (3) a material diminution in Executive’s authority, duties or responsibilities; or (4) a material change in the geographic location at which Executive performs services for the Company without Executive’s consent, which consent shall be determined in Executive’s discretion; provided, however, that Executive must notify the Company within 90 days of the occurrence (or within 90 days of learning of the occurrence, whichever is later) of any of the foregoing conditions that he considers it to be a “Good Reason” condition and provide the Company with at least 30 days in which to cure the condition.  If Executive fails to provide this notice and cure period prior to his resignation, or resigns more than six months after the initial existence of the condition, his resignation will not be deemed to be for “Good Reason.”

 

[Signature Page Follows]

 

12

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

 

	
 
    	
COMPANY
    
	
 
    	
 
    
	
 
    	
DILIGENT   CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
/s/   Brian Stafford
    
	
 
    	
Name:   Brian Stafford
    
	
 
    	
Title:   Chief Executive Officer
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
EXECUTIVE
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
/s/ Michael Stanton
    
	
 
    	
Michael   Stanton
    

 

[SIGNATURE PAGE TO EMPLOYMENT AGREEMENT]

 

 

EXHIBIT A-1

Form of Award Agreement (RSU Award)

 

RESTRICTED SHARE UNIT AWARD AGREEMENT

 

THIS RESTRICTED SHARE UNIT AWARD AGREEMENT (the “RSU Agreement”) is entered into on the date set forth in Exhibit A (the “Grant Date”) by and between DILIGENT CORPORATION, a Delaware corporation (the “Company”), and MICHAEL STANTON (the “Awardee”).

 

WHEREAS, the Company is entering into this RSU Agreement in order to effectuate the Award set forth in the Employment Agreement dated September 8, 2015 between the Company and the Awardee (the “Employment Agreement”) of a restricted share unit award with respect to the Company’s common stock, par value $0.001 per share (the “Common Stock”) pursuant to the Company’s 2013 Incentive Plan (the “2013 Plan”) on the terms and conditions provided herein.

 

NOW, THEREFORE, in consideration of the foregoing premises, the mutual covenants hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

1.                                      Award.  The Company hereby grants the Awardee the number of Restricted Stock Units (each an “RSU,” and collectively the “RSUs”) set forth in Exhibit A.  This Award is made pursuant to and is subject to the terms of the 2013 Plan.  Capitalized terms used but not otherwise defined in this RSU Agreement shall have the meanings as set forth in the 2013 Plan.

 

2.                                      Vesting.  The Award shall be subject to the vesting conditions set forth in Exhibit A.   Each RSU shall automatically convert into one share of Common Stock on the date that it becomes vested.  Subject to the terms of this Agreement, the Awardee shall forfeit the RSUs to the extent that the Awardee does not satisfy the applicable vesting requirements set forth in Exhibit A.

 

3.                                      Transfer Restrictions.  Prior to the vesting of any RSUs, the Awardee shall not be deemed to have any ownership or shareholder rights (including, without limitation, voting rights and rights to dividends or dividend equivalents) with respect to such unvested RSUs, nor may the Awardee sell, assign, pledge or otherwise transfer (voluntarily or involuntarily) unvested RSUs.

 

4.                                      Withholding Taxes.  The Company shall have the right to withhold from amounts payable to the Awardee, as compensation or otherwise, or alternatively, to require the Awardee to remit to the Company, an amount sufficient to satisfy all federal, state and local withholding tax requirements.  Notwithstanding the foregoing, if so requested by the Awardee, the Company shall, upon conversion of RSUs, provide for such withholding by withholding Common Stock that otherwise would be issued to the Awardee having a Fair Market Value on the date of such conversion that is equal to the amount necessary to satisfy the minimum statutory withholding amount.

 

1

 

5.                                      Awardee Representations.  The Awardee understands that the Awardee (and, subject to Section 4 above, not the Company) shall be responsible for the Awardee’s own tax liability arising as a result of the transactions contemplated by this RSU Agreement.

 

6.                                      Employment.  Neither this RSU Agreement nor any action taken hereunder shall be construed as giving the Awardee any right of continuing employment by the Company.

 

7.                                      Notices.  Notices or communications to be made hereunder shall be in writing and shall be made in accordance with the Employment Agreement.

 

8.                                      Governing Law.  This RSU Agreement shall be construed under the laws of the State of New York, without regard to conflict of laws principles.

 

9.                                      Entire Agreement.  This RSU Agreement, together with the Employment Agreement, constitutes the entire agreement between the parties hereto with respect to the subject matter hereof, and supersedes all prior agreements and understandings relating to the subject matter of this RSU Agreement.  Notwithstanding the foregoing, this RSU Agreement and the Award made hereby shall be subject to the terms of the 2013 Plan.

 

10.                               Binding Effect.  This RSU Agreement shall be binding upon and inure to the benefit of the Company and the Awardee and their respective permitted successors, assigns, heirs, beneficiaries and representatives.  This RSU Agreement is personal to the Awardee and may not be assigned by the Awardee without the prior consent of the Company.  Any attempted assignment in violation of this Section shall be null and void.

 

11.                               Amendment.  This RSU Agreement may be amended or modified only by a written instrument executed by both the Company and the Awardee.

 

12.                               Section 409A.  This RSU Agreement is intended to comply with the requirements of Section 409A of the Code and regulations promulgated thereunder (“Section 409A”).  To the extent that any provision in this RSU Agreement is ambiguous as to its compliance with Section 409A, the provision shall be read in such a manner so that no payments due under this RSU Agreement shall be subject to an “additional tax” as defined in Section 409A(a)(1)(B) of the Code.  For purposes of Section 409A, each payment made under this RSU Agreement shall be treated as a separate payment.  In no event may the Awardee, directly or indirectly, designate the calendar year of payment.  Notwithstanding anything contained herein to the contrary, the Awardee shall not be considered to have terminated employment with the Company for purposes of Section 3 hereof unless he would be considered to have incurred a “termination of employment” from the Company within the meaning of Treasury Regulation §1.409A-1(h)(1)(ii).  In no event shall the Committee, the Board, or the Company (or their respective employees, officers or directors) have any liability to the Awardee (or any other person) due to the failure of an Award to satisfy the requirements of Section 409A.  Although the parties endeavor to have this RSU Agreement comply with the requirements of Section 409A, there is no guarantee that the Awardee will not be subjected to the payment of any tax or interest under Section 409A, and the Awardee shall not have any right to indemnification with respect thereto.

 

2

 

13.                               Counterparts.  This RSU Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

 

[Signature Page Follows]

 

3

 

IN WITNESS WHEREOF, the parties hereto have executed this RSU Agreement or caused their duly authorized officer to execute this RSU Agreement on the date first written above.

 

	
 
    	
DILIGENT CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Name: Brian Stafford
    
	
 
    	
 
    	
Title:   Chief Executive Officer
    
	
 
    	
 
    
	
 
    	
AWARDEE
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Name:   Michael Stanton
    

 

4

 

EXHIBIT A

 

(a).                              Awardee’s Name:  Michael Stanton

 

(b).                              Grant Date:  September 8, 2015

 

(c).                               Number of RSUs Granted:  120,000

 

(d).                              Vesting Dates:  The RSUs shall vest as follows:

 

(i)  Twenty-five percent (25%) of the RSUs shall become vested on each anniversary of the Effective Date, as defined in the Employment Agreement, dated as of September 8, 2015 between the Company and the Awardee, provided that the Awardee is in the employ of the Company on such anniversary of the Effective Date.

 

(ii)  Notwithstanding the foregoing, in the event the Company consummates a Change in Control (as defined in the Plan), and Awardee’s employment is terminated without Cause (as defined in the Employment Agreement) or the Awardee resigns for Good Reason (as defined in the Employment Agreement) upon or within six (6) months following the date of such Change in Control, the RSUs, to the extent not fully vested by the date on which such termination of employment occurs, will become vested upon such termination of employment.

 

 

	
 
    	
(Initials)
    	
 
    
	
Michael   Stanton
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
(Initials)
    	
 
    
	
Company   Signatory
    	
 
    

 

5

 

EXHIBIT A-2

Form of Award Agreement (Option Award)

 

STOCK OPTION AWARD AGREEMENT

 

THIS STOCK OPTION AWARD AGREEMENT (the “Option Award Agreement”) is entered into on the date set forth on Exhibit A (the “Grant Date”) by and between DILIGENT CORPORATION, a Delaware corporation (the “Company”), and MICHAEL STANTON (the “Awardee”).

 

WHEREAS, the Company is entering into this Option Award Agreement in order to effectuate the Award set forth in the Employment Agreement dated September 8, 2015 between the Company and the Awardee (the “Employment Agreement”) of incentive stock options (the “Option”) with respect to the Company’s common stock, par value $0.001 per share (the “Common Stock”) pursuant to the Company’s 2013 Incentive Plan (the “2013 Plan”) on the terms and conditions provided herein.

 

NOW, THEREFORE, in consideration of the foregoing premises, the mutual covenants hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

1.                                      Award.  Subject to the terms and conditions of this Option Award Agreement, the Company hereby grants to the Awardee an Option to purchase the number of Shares set forth in Exhibit A on the terms and conditions set forth in Exhibit A.  This award is made pursuant to and is subject to the terms of the 2013 Plan.  Capitalized terms used but not otherwise defined in this Agreement shall have the meanings as set forth in the 2013 Plan.  To the extent designated as an incentive stock option (“ISO”), this Option is intended to qualify as an incentive stock option under Section 422 of the Code.  However, notwithstanding such designation, if the Awardee becomes eligible in any given year to exercise ISOs for Shares having a Fair Market Value in excess of $100,000, those Options representing the excess shall be treated as non-qualified stock options (“NSOs”).  In the previous sentence, “ISOs” include ISOs granted under any plan of the Company or any parent or any subsidiary.  For the purpose of deciding which Options apply to Shares that “exceed” the $100,000 limit, ISOs shall be taken into account in the same order as granted.  The Fair Market Value of the Shares shall be determined as of the time the Option with respect to such Shares is granted.  The Awardee hereby acknowledges that there is no assurance that the Option will, in fact, be treated as an incentive stock option under Section 422 of the Code.

 

2.                                    Conditions of Exercise.  This Option may not be exercised unless all of the following conditions are met:

 

(a)                                 Counsel for the Company must be satisfied at the time of exercise that the issuance of Shares upon exercise of this Option will be in compliance with the Securities Act of 1933, as amended, and all other applicable federal and state laws.

 

(b)                                 The Awardee must give the Company written notice of exercise specifying

 

1

 

the number of Shares with respect to which this Option is being exercised, and at the time of exercise pay the full purchase price for the Shares being acquired (i) in cash or check acceptable to the Company, (ii) by surrender of Shares that otherwise would have been delivered to the Awardee upon exercise of the Option, up to the largest whole number of Shares having an aggregate Fair Market Value that does not exceed the aggregate exercise price (plus tax withholdings, if applicable) and any remaining balance of the aggregate exercise price (and/or applicable tax withholdings) not satisfied by such reduction in the number of whole Shares to be issued shall be paid by the Awardee in cash or other form of payment permitted under this Option, or (iii) by such other manner as the Committee may authorize.

 

(c)                                  The Awardee must at all times during the period beginning with the Grant Date and ending on the date of such exercise have been an employee or a member of the board of directors of the Company (or of a corporation or a parent or subsidiary of a corporation assuming this Option by reason of a corporate merger, consolidation, acquisition of property or stock, separation, reorganization or liquidation in a transaction to which Section 424(a) of the Code applies), provided, however, that:

 

(i)                               if the Awardee ceases to be an employee of the Company due to termination of employment by the Company without Cause (as defined in the Employment Agreement) or the Awardee’s resignation from employment with the Company with or without Good Reason (as defined in the Employment Agreement), this Option will remain in full force and effect and may be exercised, to the extent exercisable on the date of termination, until the earlier of (x) ninety (90) days from the date of the Awardee’s termination of employment or (y) the expiration of this Option, and

 

(ii)                            if the Awardee ceases to be an employee of the Company due to death or Disability (as defined in the Employment Agreement), this Option will remain in full force and effect and may be exercised, to the extent exercisable on the date of termination, until the earlier of (x) one (1) year from the date of the Awardee’s termination of employment or (y) the expiration of this Option.

 

For avoidance of doubt, it the Awardee ceases to be an employee of the Company due to termination of employment by the Company for Cause, this Option shall immediately terminate on the date of such termination and shall not be exercisable for any period following such date.

 

(d)                                 The Company shall have the right to withhold from amounts payable to the Awardee, as compensation or otherwise, or alternatively, to require the Awardee to remit to the Company, an amount sufficient to satisfy all federal, state and local withholding tax requirements.  Notwithstanding the foregoing, if so requested by the Awardee, the Company shall provide for such withholding by withholding Common Stock that otherwise would be issued to the Awardee upon exercise of the Option having a Fair Market Value equal to the amount necessary to satisfy the minimum statutory withholding amount.

 

 

(e)                                  The Shares covered by this Option have been listed (subject only to official notice of issuance) on any national securities exchange on which the Common Stock is then listed.

 

3.                                      Restrictions on Transfer and Exercise.

 

(a)                                 Except as provided in this Section 3, this Option, and rights under this Option, may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Awardee and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company.

 

(b)                                 This Option shall be exercisable only by the Awardee (or, in the case of Awardee’s Disability, by Awardee’s personal representative) during the Awardee’s lifetime, or by the person to whom the Awardee’s rights shall pass by will or the laws of descent and distribution.  Notwithstanding anything in the 2013 Plan to the contrary, an award of NSOs shall be transferable pursuant to a domestic relations order.

 

(c)                                  If at the time of the Awardee’s death this Option has not been fully exercised, the Awardee’s estate or any person who acquires the right to exercise this Option by bequest or inheritance or by reason of the Awardee’s death may, at any time within one year after the date of the Awardee’s death, exercise this Option with respect to up to the entire remaining number of Shares subject to this Option.  It shall be a condition to the exercise of this Option after the Awardee’s death that the Company shall have been furnished evidence satisfactory to it of the right of the person exercising this Option to do so and that all estate, transfer, inheritance or death taxes payable with respect to this Option or the Shares to which it relates have been paid or otherwise provided for to the satisfaction of the Company.

 

4.                                      Awardee Representations.  The Awardee understands that the Awardee (and, subject to Section 2(d) above, not the Company) shall be responsible for the Awardee’s own tax liability arising as a result of the transactions contemplated by this Agreement.

 

5.                                      No Right to Continued Employment.  By accepting this Option Award Agreement, the Awardee acknowledges and agrees that neither the grant of this Option nor any of the terms herein (including the exercise schedule) constitute an express or implied promise of continued employment or service for the exercise period or for any other period, and shall not interfere with the Awardee’s right or the right of the Company to terminate the employment or service relationship at any time, with or without cause, subject to the terms of any written employment agreement that the Awardee may have entered into with the Company.

 

6.                                      Notices.  Notices or communications to be made hereunder shall be in writing and shall be made in accordance with the Employment Agreement.

 

 

7.                                      Governing Law.  This Option Award Agreement shall be construed under the laws of the State of New York, without regard to conflict of laws principles.

 

8.                                      Entire Agreement.  This Option Award Agreement, together with the Employment Agreement, constitutes the entire agreement between the parties hereto with respect to the subject matter hereof, and supersedes all prior agreements and understandings relating to the subject matter of this Option Award Agreement.  Notwithstanding the foregoing, this Option Award Agreement and the Award made hereby shall be subject to the terms of the 2013 Plan.

 

9.                                      Section 409A.  This Option Award Agreement is intended to comply with the requirements of Section 409A of the Code and regulations promulgated thereunder (“Section 409A”).  To the extent that any provision in this Option Award Agreement is ambiguous as to its compliance with Section 409A, the provision shall be read in such a manner so that no payments due under this Agreement shall be subject to an “additional tax” as defined in Section 409A(a)(1)(B) of the Code.  In no event shall the Committee, the Board, or the Company (or their respective employees, officers or directors) have any liability to the Awardee (or any other person) due to the failure of an award to satisfy the requirements of Section 409A.  Although the parties endeavor to have this Option Award Agreement comply with the requirements of Section 409A, there is no guarantee that the Awardee will not be subjected to the payment of any tax or interest under Section 409A, and the Awardee shall not have any right to indemnification with respect thereto.

 

[Signature Page Follows]

 

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement or caused their duly authorized officer to execute this Agreement on the date first written above.

 

	
 
    	
DILIGENT CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Name: Brian Stafford
    
	
 
    	
 
    	
Title:   Chief Executive Officer
    
	
 
    	
 
    
	
 
    	
AWARDEE
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Name:   Michael Stanton
    

 

 

EXHIBIT A

 

(a).                              Awardee’s Name:  Michael Stanton

 

(b).                              Grant Date:  September 8, 2015

 

(c)                                  Number of Shares Covered By This Option: 240,000

 

(d)                                 Exercise Price: $3.10 USD

 

(e)                                  Expiration Date: September 8, 2025

 

(f)                                   Exercise Schedule:  The Shares shall vest as follows:

 

(i)  One-fourth of the Shares covered by this Option shall become vested on each anniversary of the Effective Date (as defined in the Employment Agreement), provided that the Awardee is in the employ of the Company as an executive officer on such anniversary of the Effective Date.

 

(ii)  Notwithstanding the foregoing, in the event the Company consummates a Change in Control (as defined in the Plan), and Awardee’s employment is terminated without Cause (as defined in the Employment Agreement) or the Awardee resigns for Good Reason (as defined in the Employment Agreement) upon or within six (6) months following the date of such Change in Control, the Shares covered by this Option, to the extent not fully vested by the date on which such termination of employment occurs, will become vested upon such termination of employment.

 

 

	
 
    	
(Initials)
    	
 
    
	
Michael   Stanton
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
(Initials)
    	
 
    
	
Company   Signatory
    	
 
    

 

 

EXHIBIT A-3

Form of Award Agreement (Performance Share Unit Award)

 

PERFORMANCE SHARE UNIT AWARD AGREEMENT

 

THIS PERFORMANCE SHARE UNIT AWARD AGREEMENT (the “Performance Share Unit Award Agreement”) is entered into on the date set forth in Exhibit A (the “Grant Date”) by and between DILIGENT CORPORATION, a Delaware corporation (the “Company”), and MICHAEL STANTON (the “Awardee”).

 

WHEREAS, the Company is entering into this Performance Share Unit Award Agreement in order to effectuate the Award set forth in the Employment Agreement dated September 8, 2015 between the Company and the Awardee (the “Employment Agreement”) of Restricted Share Units with respect to the Company’s common stock, par value $0.001 per share (the “Common Stock”) pursuant to the Company’s 2013 Incentive Plan (the “2013 Plan”) on the terms and conditions provided herein.

 

NOW, THEREFORE, in consideration of the foregoing premises, the mutual covenants hereinafter set forth and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

 

1.                                      Award.  Subject to Section 2 hereof, in the event that the Committee has certified that one or more performance targets set forth in Exhibit A (each, a “Performance Hurdle”) has been achieved (the date of such determination, the “Determination Date”), the Company shall issue and deliver to the Awardee 60,000 shares of Common Stock in respect of each such Performance Hurdle, for a total of 240,000 shares of Common Stock if all Performance Hurdles are achieved (the “Performance Shares”); provided that, subject to Section 2 hereof, the Awardee is in the employ of the Company on such Determination Date.  This Award is made pursuant to and is subject to the terms of the 2013 Plan.  Capitalized terms used but not otherwise defined in this Performance Share Unit Award Agreement shall have the meanings as set forth in the 2013 Plan.

 

2.                                      Acceleration Upon Change in Control.  In the event that the Company consummates a Change in Control (as defined in the Plan) during the Performance Period, and Awardee’s employment is terminated without Cause (as defined in the Employment Agreement) or the Awardee resigns for Good Reason (as defined in the Employment Agreement) upon or within six (6) months following the date of such Change in Control (as defined in Exhibit A hereto), the Awardee shall be entitled to the number of Performance Shares eligible to be earned under this Performance Share Unit Award Agreement, less any Performance Shares previously delivered.  The Company shall issue and deliver the applicable Performance Shares immediately prior to such Change in Control.  Notwithstanding anything contained herein to the contrary, delivery of Performance Shares to a “specified employee” as defined in Section 409A(a)(2)(B) of the Code shall be deferred until the first business day of the seventh month following such employee’s separation from service with the Company if earlier delivery would cause a violation of Section 409A of the Code.

 

3.                                      Transfer Restrictions.  Prior to the vesting of any Performance Share Units, the Awardee shall not be deemed to have any ownership or shareholder rights (including, without

 

1

 

limitation, voting rights and rights to dividends or dividend equivalents) with respect to such unvested Performance Share Units, nor may the Awardee sell, assign, pledge or otherwise transfer (voluntarily or involuntarily) unvested Performance Share Units.

 

5.                                      Withholding Taxes.  The Company shall have the right to withhold from amounts payable to the Awardee, as compensation or otherwise, or alternatively, to require the Awardee to remit to the Company, an amount sufficient to satisfy all federal, state and local withholding tax requirements.  Notwithstanding the foregoing, if so requested by the Awardee, the Company shall, upon conversion of Performance Share Units, provide for such withholding by withholding Common Stock that otherwise would be issued to the Awardee having a Fair Market Value on the date of such conversion that is equal to the amount necessary to satisfy the minimum statutory withholding amount.

 

6.                                      Awardee Representations.  The Awardee understands that the Awardee (and, subject to Section 5 above, not the Company) shall be responsible for the Awardee’s own tax liability arising as a result of the transactions contemplated by this Performance Share Unit Award Agreement.

 

7.                                      Employment.  Neither this Performance Share Unit Award Agreement nor any action taken hereunder shall be construed as giving the Awardee any right of continuing employment by the Company.

 

8.                                      Notices.  Notices or communications to be made hereunder shall be in writing and shall be made in accordance with the Employment Agreement.

 

9.                                      Governing Law.  This Performance Share Unit Award Agreement shall be construed under the laws of the State of New York, without regard to conflict of laws principles.

 

10.                               Entire Agreement.  This Performance Share Unit Award Agreement, together with the Employment Agreement, constitutes the entire agreement between the parties hereto with respect to the subject matter hereof, and supersedes all prior agreements and understandings relating to the subject matter of this Performance Share Unit Award Agreement.  Notwithstanding the foregoing, this Performance Share Unit Award Agreement and the Award made hereby shall be subject to the terms of the 2013 Plan.

 

11.                               Binding Effect.  This Performance Share Unit Award Agreement shall be binding upon and inure to the benefit of the Company and the Awardee and their respective permitted successors, assigns, heirs, beneficiaries and representatives.  This Performance Share Unit Award Agreement is personal to the Awardee and may not be assigned by the Awardee without the prior consent of the Company.  Any attempted assignment in violation of this Section shall be null and void.

 

12.                               Amendment.  This Performance Share Unit Award Agreement may be amended or modified only by a written instrument executed by both the Company and the Awardee.

 

2

 

13.                               Section 409A.  This Performance Share Unit Award Agreement and the Performance Shares covered hereby are intended to comply with the requirements of the short-term deferral exception under Section 409A of the Code and regulations promulgated thereunder (“Section 409A”).  To the extent that any provision in this Performance Share Unit Award Agreement is ambiguous as to its compliance with the short-term deferral exception or any other provision of Section 409A, the provision shall be read in such a manner so that no payments due under this Performance Share Unit Award Agreement shall be subject to an “additional tax” as defined in Section 409A(a)(1)(B) of the Code.  For purposes of Section 409A, each payment made under this Performance Share Unit Award Agreement shall be treated as a separate payment.  Notwithstanding anything contained herein to the contrary, the Awardee shall not be considered to have terminated employment with the Company for purposes of Section 2 hereof unless he would be considered to have incurred a “termination of employment” from the Company within the meaning of Treasury Regulation §1.409A-1(h)(1)(ii).  In no event shall the Committee, the Board, or the Company (or their respective employees, officers or directors) have any liability to the Awardee (or any other person) due to the failure of an Award to satisfy the requirements of Section 409A.  Although the parties endeavor to have this Performance Share Unit Award Agreement comply with the requirements of Section 409A, there is no guarantee that the Awardee will not be subjected to the payment of any tax or interest under Section 409A, and the Awardee shall not have any right to indemnification with respect thereto.

 

14.                               Section 162(m): Promptly following the filing of the Company’s Quarterly Report on Form 10-Q, or, in the case of the Company’s fourth fiscal quarter, following the filing of the Company’s Annual Report on Form 10-K, in each case covering fiscal periods ending prior to the sixth anniversary of the Grant Date, the Committee will review and certify in writing whether one or more Performance Hurdles have been achieved.  All payments under this Performance Share Unit Award Agreement are intended to constitute “qualified performance-based compensation” within the meaning of Section 162(m) of the Code.  This Award shall be construed and administered in a manner consistent with such intent.

 

15.                               Counterparts.  This Performance Share Unit Award Agreement may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.

 

[Signature Page Follows]

 

3

 

IN WITNESS WHEREOF, the parties hereto have executed this Performance Share Unit Award Agreement or caused their duly authorized officer to execute this Performance Share Unit Award Agreement on the date first written above.

 

	
 
    	
DILIGENT CORPORATION
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
Name: Brian Stafford
    
	
 
    	
 
    	
Title:   Chief Executive Officer
    
	
 
    	
 
    
	
 
    	
AWARDEE
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
Name:   Michael Stanton
    

 

4

 

EXHIBIT A

 

(a).                              Awardee’s Name:  Michael Stanton

 

(b).                              Grant Date: September 8, 2015

 

(c).                               Total Performance Shares available to be earned:  240,000

 

(d).                              Performance Hurdles:  Each of the Performance Hurdles described below may be achieved only once, but multiple Performance Hurdles may be achieved concurrently (for example, if LTM Revenue (as defined below) is $150 million, and was no more than $100 million in prior measurement periods, the first two Performance Hurdles would be achieved concurrently):

 

1.              Revenue of the Company for the last twelve completed months prior to the end of its most recently completed fiscal quarter, calculated in accordance with GAAP (“LTM Revenue”), as reflected in its financial statements filed with the Securities and Exchange Commission (“SEC Financials”), is greater than $116 million;

2.              LTM Revenue of the Company as reflected in its SEC Financials is greater than $143 million;

3.              LTM Revenue of the Company as reflected in its SEC Financials is greater than $178 million; and

4.              LTM Revenue of the Company as reflected in its SEC Financials is greater than $220 million.

 

Performance Hurdles must be achieved during a measurement period ending prior to the sixth anniversary of the Grant Date (the “Performance Period”).  In each case, LTM Revenue will be adjusted to exclude revenue attributable to businesses acquired after the Effective Date, if any.

 

 

	
 
    	
(Initials)
    	
 
    
	
Michael   Stanton
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
 
    	
(Initials)
    	
 
    
	
Company   Signatory
    	
 
    

 

5

 

EXHIBIT B

 

Assignment of Invention, Non-Disclosure and Non-Solicitation Agreement

 

 

ASSIGNMENT OF INVENTIONS, NON-DISCLOSURE AND NON-SOLICITATION AGREEMENT

 

Employee Name: Michael Stanton (referred to herein as “I” or “Employee).

 

In order for Diligent Corporation and its direct and indirect subsidiaries and its and their successors and assigns (herein collectively referred to as the “Company”) to maintain a competitive edge, the Company must protect its inventions, discoveries, works of authorship and its proprietary technical and business information, as well as the goodwill and specialized training that employees are given access to as part of their employment.

 

Therefore, as a condition of employment with the Company, and where required by applicable law, additional consideration that may be provided to me by the Company (such as, by way of example, bonuses, raises, promotions and the like), the Company and I agree as follows:

 

DEFINITIONS

 

1.              “Inventions” means any new or useful art, discovery, new contribution, finding or improvement (including without limitation any technology, computer programs, test, concept, idea, apparatus, device, mechanism, equipment, machinery, process, method, composition of matter, formula or technique), whether or not patentable, and all know-how related thereto, that has been made, created, developed, written or conceived by me (i) in the course of performing duties for the Company, (ii) relating to the actual or anticipated business of the Company, or (iii) with the use of the Company’s time, material, proprietary information, Confidential Information or facilities.

 

2.              “Works” means any materials for which copyright protection may be obtained, including without limitation literary works (including books, pamphlets, articles and other writings), mask works, artistic works (including designs, graphs, drawings, blueprints and other graphic works), computer programs, compilations, recordings, photographs, motion pictures and other audio-visual works that have been made, created, developed, written or conceived by me (i) in the course of my employment, (ii) relating to the actual or anticipated business of the Company, or (iii) with the use of the Company’s time, material, proprietary information, Confidential Information or facilities.

 

3.              “Confidential Information” means information or a compilation of information in any form: (i) disclosed to or known by me as a consequence of my employment with the Company, (ii) not generally known to others outside the Company, and (iii) which relates to the business of the Company.  Confidential Information includes, but is not limited to: trade secrets and other information relating to the Company’s research, development efforts and methodologies, testing, engineering, manufacturing, marketing, sales, finances, operations (including without limitation any processes,

 

1

 

formulae, methods, techniques, devices, know-how, manufacturing, processes, customer and prospect lists, sales statistics, tactics and projections, marketing strategies and plans, and human resources information obtained from a confidential personnel file (such as internal evaluations of the performance, capability and potential of any Company employee)), or non-public information of third parties which was entrusted to the Company in confidence.

 

DISCLOSURE AND ASSIGNMENT OF INVENTIONS AND WORKS

 

4.              I will promptly disclose to the Company in writing, all Inventions and Works which are or have been conceived, made, discovered, written or created by me alone or jointly with someone else on the Company’s time or on my own time, while I have been or continued to be employed by the Company.

 

5.              All Works created by me, alone or with others, are and shall be deemed “works made for hire” under the copyright laws and are and shall be owned by the Company.

 

6.              Subject to paragraph 11 below, I hereby assign to the Company all of my rights, title and interest in all Inventions, and in all Works to the extent such Works may not, by operation of law, be works made for hire.

 

7.              I will give the Company all assistance it reasonably requires to perfect, protect, and use its rights to Inventions and Works. In particular, I will sign all documents, do all things, and supply all information that the Company considers necessary or desirable to transfer or record the transfer of my entire right, title and interest in Inventions and Works; and to enable the Company to obtain patent, copyright, or other legal protection for Inventions and Works. Any out-of-pocket expenses will be paid by the Company.

 

8.              I acknowledge that my work responsibilities may require me to create, develop or work on Inventions on behalf of the Company. I will immediately communicate to the President of the Company (or such other individual as the President may designate from time to time) a full and complete disclosure of each and every Invention conceived or made by me whether solely or jointly with others (a) while in the employ of the Company, whether or not while actually engaged in the Company’s affairs, and (b) within two years subsequent to termination of said employment for any reason.

 

9.              I agree to assign and transfer, and do hereby assign and transfer to the Company, without any separate remuneration or compensation other than the wages or salary received or compensation paid to me from time to time in the course of my employment by the Company, my entire right, title and interest in and to all

 

2

 

Inventions and Works conceived or made by me, together with all United States and foreign patent rights and any other legal protection in and with respect to any and all such Inventions and Works (a) while in the employ of the Company, whether or not while I was actually engaged  in the Company’s affairs, or (b) within two years subsequent thereto that were a direct or indirect result of such employment.  Upon request by the Company, I agree to execute and deliver all appropriate patent applications for securing all United States and foreign patents on all such Inventions, and to do, execute, and deliver any and all acts and instruments that may be necessary or proper to vest all such Inventions and patents in the Company or its designee, and to enable the Company or its designee to obtain all such letters patent. I agree to render to the Company or its designee all such assistance as it may require in the prosecution of all such patent applications and applications for the reissue of such patents and in the prosecution or defense of all interferences which may be declared involving any of said patent applications or patents. I further agree not to contest the validity of any patent, United States or foreign, which is issued to the Company or its designee, on which I made any contribution, or in which I participated in any way, and not to assist any other party in any way in contesting the validity of any such patent. I further agree that the obligations and undertakings stated in this paragraph shall continue beyond the termination of my employment by the Company, but if I shall be called upon to render such assistance after the termination of this employment, I shall be entitled to a fair and reasonable per diem fee in addition to reimbursement of any expenses incurred at the request of the Company.

 

10.       As a matter of record, I understand that I may include a complete list of inventions and works made by me prior to the date of employment by the Company as an appendix to this Agreement. Only those inventions and works so listed shall be deemed to be excluded from the terms and conditions of this Agreement.  Other than these, I do not claim to own or control rights in any inventions or works subject to copyright and will not assert any such rights against the Company.

 

11.       To the extent that Employee is a citizen of California and subject to its law, then Employee is notified that the foregoing assignment shall not include inventions excluded under Cal. Lab. Code § 2870 which provides: “(a) Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions that either: (1) relate at the time of concept or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or (2) result from any work

 

3

 

performed by the employee for the employer”, and to the extent Employee is a citizen of and subject to the law of another state which provides a similar limitation on invention assignments then Employee is notified that the foregoing assignment shall not include inventions excluded under such law (namely North Carolina General Statutes Article 10A, Chapter 66, Commerce and Business, Section 66-57.1).

 

NONDISCLOSURE OF CONFIDENTIAL INFORMATION

 

12.       I will not disclose or use any of the Confidential Information for the benefit of myself or another, unless directed or authorized in writing by the Company to do so.

 

13.       I understand that if I possess any proprietary information of another person or company as a result of prior employment or otherwise, the Company expects and requires that I will honor any and all legal obligations that I have to that person or company with respect to proprietary information, and I will refrain from any unauthorized use or disclosure of such information.

 

14.       Confidential Information does not include information lawfully acquired by a non-management employee about wages, hours or other terms and conditions of non-management employees if used by them for purposes protected by §7 of the National Labor Relations Act (the NLRA) such as joining or forming a union, engaging in collective bargaining, or engaging in other concerted activity for their mutual aid or protection.

 

15.       Nothing in this Agreement, including the foregoing, prevents an employee from communicating with the EEOC, the SEC, the DOL, or any other governmental authority, making a report in good faith and with a reasonable belief of any violations of law or regulation to a governmental authority, or cooperating with or participating in a legal proceeding relating to such violations.

 

16.       This Agreement does not alter, reduce or modify any obligations Employee owes to the Company under any other applicable statute or the common law.

 

INSIDER TRADING

 

17.       I hereby affirm that I am aware of and understand my responsibility to safeguard Confidential Information, and will not use or share such information for securities trading purposes or for any other purpose except to conduct Company business.  To use non-public information for personal financial benefit or to “tip” others who might make an investment decision on the basis of this information is not only unethical but also illegal.  Unauthorized use, disclosure or distribution of this information may result in disciplinary action and could also be illegal and result in criminal and civil penalties.

 

4

 

RETURN OF COMPANY PROPERTY

 

18.       All documents and other tangible property relating in any way to the business of the Company are the exclusive property of the Company (even if I authored or created them). I agree to return all such documents, including but not limited to those that constitute or contain any Confidential Information or Inventions and Works, and tangible property to the Company upon termination of employment or at such earlier time as the Company may request me to do.

 

NON-SOLICITATION OF ACCOUNTS

 

19.       During my employment and for one (1) year after termination of employment with the Company, I will not, directly or indirectly, solicit, induce, or attempt to induce any past, current or prospective customer of the Company whose identities were made known to me, with which I had business-related contact, or about which I received Confidential Information during the last two (2) years of employment or such shorter period of time as I have been employed (the “Look Back Period”): (a) to stop doing business with or through the Company, or (b) to do business with any business whose products and services include products and services offered by the Company regarding which I had material involvement or received Confidential Information about during the Look Back Period (such products and services being “Competing Products and Services” and such business being a “Competitor”).

 

NON-SOLICITATION OF EMPLOYEES

 

20.       During my employment by the Company and for one (1) year thereafter, I shall not, directly or indirectly, solicit or induce or attempt to solicit or induce any employee of the Company to: (a) terminate his or her employment with the Company; or (b) accept employment or affiliation with another firm or entity of which I am an employee, owner, partner or consultant.

 

SEVERABILITY AND REFORMATION

 

21.       Should any restriction on Employee created by this Agreement be deemed unreasonable or unenforceable as written, then the parties recognize and agree that a court may modify any unreasonable or unenforceable element of the restriction (such as time, geography, or scope of activity restrained) to make it reasonable and enforceable or enforce it only to the extent it is reasonable and enforceable; to the maximum amount allowed by law to protect Company’s legitimate business interests.  The provisions of this Agreement separate and severable, and to the extent that any illegal or unenforceable provision of this Agreement cannot be cured by reformation, then such offending portion or language shall be stricken from this Agreement and the remainder of this Agreement shall continue in effect.

 

5

 

GOVERNING LAW

 

22.       This Agreement will be governed exclusively by, and be construed and enforced in accordance with, the laws of the state where Employee is domiciled on the date of Employee’s separation, or if a current employee his/her domicile on the date Employee breaches this agreement.

 

BURDEN AND BENEFIT

 

23.       The Company may assign its rights and delegate its duties and obligations under this Agreement to any successor in interest, whether by merger, consolidation, sale of assets, or otherwise. This Agreement shall be binding whether it is between me and the Company or between me and any successor or assigns of the company.  I understand that I may not assign any of my rights and obligations under this Agreement, except with the prior written consent of the President of the Company.

 

NO EFFECT ON TERM OF EMPLOYMENT; TERM

 

24.       Nothing in this Agreement prevents or limits my right to terminate my employment at any time for any reason, and nothing in this Agreement prevents or limits the Company from terminating my employment at any time for any reason. I understand and agree that there exist no promises or guarantees of permanent employment or employment for any specified term by the Company. I acknowledge and agree that the terms and conditions hereof memorialize the agreement that has governed my employment by the Company since I was first employed by the Company, whether as an employee or independent contractor.

 

25.       I agree that injunctive or other equitable relief would be necessary to remedy any breach of my duties or obligations under this Agreement, and I waive the posting of a bond by the Company in connection with such relief.

 

GENERAL

 

26.       I understand that this Agreement contains the entire agreement and understanding between the Company and me with respect to the provisions contained in this Agreement, and that no representations, promises, agreements, or understandings, written or oral, related thereto which are not contained in this Agreement will be given any force or effect. No change or modification of this Agreement will be valid or binding unless it is in writing and signed by the party against whom the change or modification is sought to be enforced or is by order of a court of competent jurisdiction. I further understand that even if the Company waives or fails to enforce any provision of this Agreement in one instance that will not constitute a waiver of any other provisions of this Agreement at this time, or a waiver of that provision at any other time. My obligations under this Agreement shall survive the termination of my employment regardless of the manner of such termination and shall, likewise, continue to apply and be valid notwithstanding any change in my duties,

 

6

 

compensation, responsibilities, position or title and/or the assignment of this Agreement by the Company to any successor in interest or other assignee.

 

27.       If I violate one of the post-employment restrictions in this Agreement on which there is a specific time limitation, the time period for that restriction will be extended by one day for each day I violate it, up to a maximum extension equal to the length of time originally prescribed for the restriction, so as to give Company the full benefit of the bargained-for length of forbearance.

 

28.       I will provide a copy of this Agreement to any person, firm, association, or corporation that I intend to be employed by, associate with, or provide consulting services for in order to insure compliance with this Agreement.  I understand that both the Company and I have the right to provide another party an opinion about interpretation and/or application of this Agreement; I consent to such communication, and agree not to assert a claim of wrongdoing by the Company as a result of such a communication.

 

 

	
AGREED:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Diligent   Corporation
    
	
 
    	
 
    	
 
    
	
Employee:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
By:
    	
 
    	
 
    	
By:
    	
 
    
	
Name:   Michael Stanton
    	
 
    	
Name:   Brian Stafford
    
	
Date:   September 8, 2015
    	
 
    	
Title:   Chief Executive Officer
    
					

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00249-of-00352.parquet"}]]